Ignite Creation Date:
2025-12-24 @ 3:27 PM
Ignite Modification Date:
2025-12-24 @ 3:27 PM
Study NCT ID:
NCT02935192
Status:
COMPLETED
Last Update Posted:
2019-04-19
First Post:
2016-10-13
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Phase 3 Trial of Serbian Seasonal Influenza Vaccine
Sponsor:
Institute of Virology, Vaccines and Sera, Torlak
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11-28
Start Date Type:
ACTUAL
Primary Completion Date:
2017-01-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-25
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-13
First Submit QC Date:
None
Study First Post Date:
2016-10-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-18
Results First Submit QC Date:
None
Results First Post Date:
2019-04-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-21
Last Update Post Date:
2019-04-19
Last Update Post Date Type:
ACTUAL